Global excellence in rheumatology in Latin America: The case of systemic lupus erythematosus

Manuel F. Ugarte-Gil; Yurilis Fuentes-Silva; Victor R. Pimentel-Quiroz; Guillermo J. Pons-Estel; Rosana Quintana; Bernardo A. Pons-Estel; Graciela S. Alarcón

doi:10.3389/fmed.2022.988191

Global excellence in rheumatology in Latin America: The case of systemic lupus erythematosus

Manuel F. Ugarte-Gil, Yurilis Fuentes-Silva, Victor R. Pimentel-Quiroz, Guillermo J. Pons-Estel, Rosana Quintana, Bernardo A. Pons-Estel, Graciela S. Alarcón

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Systemic lupus erythematosus (SLE) affects more severely non-White populations, due to their genetic background and sociodemographic characteristics. Several studies have evaluated Latin American SLE patients to determine their genetic and clinical characteristics as well as prognostic factors; these studies have not only allowed the development of treatment guidelines aimed at the region but also to support regional and global projects. Additionally, educational activities in Spanish and Portuguese have been started to reduce our patients’ health illiteracy. Despite the relatively low research output from Latin American countries, we consider that studies from our region coupled with the networks developed to increase our capabilities, could be a model for other rare autoimmune diseases.

Original language	English
Article number	988191
Journal	Frontiers in Medicine
Volume	9
DOIs	https://doi.org/10.3389/fmed.2022.988191
State	Published - 11 Jan 2023

Keywords

Hispanic
Latin America
South America
disparities
education
prognosis
research
systemic lupus erythematosus (SLE)

Access to Document

10.3389/fmed.2022.988191

Cite this

@article{0815fa4caa284c9286166bcd79bf57e8,

title = "Global excellence in rheumatology in Latin America: The case of systemic lupus erythematosus",

abstract = "Systemic lupus erythematosus (SLE) affects more severely non-White populations, due to their genetic background and sociodemographic characteristics. Several studies have evaluated Latin American SLE patients to determine their genetic and clinical characteristics as well as prognostic factors; these studies have not only allowed the development of treatment guidelines aimed at the region but also to support regional and global projects. Additionally, educational activities in Spanish and Portuguese have been started to reduce our patients{\textquoteright} health illiteracy. Despite the relatively low research output from Latin American countries, we consider that studies from our region coupled with the networks developed to increase our capabilities, could be a model for other rare autoimmune diseases.",

keywords = "Hispanic, Latin America, South America, disparities, education, prognosis, research, systemic lupus erythematosus (SLE)",

author = "Ugarte-Gil, {Manuel F.} and Yurilis Fuentes-Silva and Pimentel-Quiroz, {Victor R.} and Pons-Estel, {Guillermo J.} and Rosana Quintana and Pons-Estel, {Bernardo A.} and Alarc{\'o}n, {Graciela S.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2023 Ugarte-Gil, Fuentes-Silva, Pimentel-Quiroz, Pons-Estel, Quintana, Pons-Estel and Alarc{\'o}n.",

year = "2023",

month = jan,

day = "11",

doi = "10.3389/fmed.2022.988191",

language = "Ingl{\'e}s",

volume = "9",

journal = "Frontiers in Medicine",

issn = "2296-858X",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Global excellence in rheumatology in Latin America

T2 - The case of systemic lupus erythematosus

AU - Ugarte-Gil, Manuel F.

AU - Fuentes-Silva, Yurilis

AU - Pimentel-Quiroz, Victor R.

AU - Pons-Estel, Guillermo J.

AU - Quintana, Rosana

AU - Pons-Estel, Bernardo A.

AU - Alarcón, Graciela S.

PY - 2023/1/11

Y1 - 2023/1/11

N2 - Systemic lupus erythematosus (SLE) affects more severely non-White populations, due to their genetic background and sociodemographic characteristics. Several studies have evaluated Latin American SLE patients to determine their genetic and clinical characteristics as well as prognostic factors; these studies have not only allowed the development of treatment guidelines aimed at the region but also to support regional and global projects. Additionally, educational activities in Spanish and Portuguese have been started to reduce our patients’ health illiteracy. Despite the relatively low research output from Latin American countries, we consider that studies from our region coupled with the networks developed to increase our capabilities, could be a model for other rare autoimmune diseases.

AB - Systemic lupus erythematosus (SLE) affects more severely non-White populations, due to their genetic background and sociodemographic characteristics. Several studies have evaluated Latin American SLE patients to determine their genetic and clinical characteristics as well as prognostic factors; these studies have not only allowed the development of treatment guidelines aimed at the region but also to support regional and global projects. Additionally, educational activities in Spanish and Portuguese have been started to reduce our patients’ health illiteracy. Despite the relatively low research output from Latin American countries, we consider that studies from our region coupled with the networks developed to increase our capabilities, could be a model for other rare autoimmune diseases.

KW - Hispanic

KW - Latin America

KW - South America

KW - disparities

KW - education

KW - prognosis

KW - research

KW - systemic lupus erythematosus (SLE)

UR - http://www.scopus.com/inward/record.url?scp=85147013605&partnerID=8YFLogxK

U2 - 10.3389/fmed.2022.988191

DO - 10.3389/fmed.2022.988191

M3 - Artículo de revisión

AN - SCOPUS:85147013605

SN - 2296-858X

VL - 9

JO - Frontiers in Medicine

JF - Frontiers in Medicine

M1 - 988191

ER -

Global excellence in rheumatology in Latin America: The case of systemic lupus erythematosus

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this